Clinical Trial Update: Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating whether gamma-glutamylcysteine supplementation can enrich glutathione levels in Parkinson's disease patients and is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Gamma-glutamylcysteine (gamma-glutamylcysteine)

Snippet

Sponsor: Pravat Mandal | Conditions: Parkinsons Disease (PD) | Phase 1 | Status: RECRUITING